+ Watch RAD
on My Watchlist
The Company is a Delaware corporation and through its wholly-owned subsidiaries, operates retail drugstores in the United States of America.
Seems rising interest rates could be a problem.End ASAP , too difficult for real money. BuffettJunior1 (97.48) Submitted: 3/14/2012 4:50:26 PM : Start Price: $2.10 RAD Score: -13.48This is a slow growth business that is consistently losing money. The company has very little cash on hand and about $6.2 billion in long-term debt. Overall, the company has a market cap of $1.8 billion and an enterprise value of approximately $8 billion. Now, I don’t know about you people but to me this stock seems grossly overvalued. In fact, I am willing to bet good money that this company won’t be around 5 years from now. The company is taking on an ever increasing amount of debt every year and is struggling to cover its interest expense. This cannot go on forever; eventually the company will be forced to declare bankruptcy. This stock might do well in the short-term; however, in the long run I can almost guarantee that it will become worthless.
$5,80 score minus 97,67 , cashflow, PE 18 , no growth. Highly leveraged. http://www.gurufocus.com/stock/RAD
cash is rising and expenses of remodeling stores is about over. $200 mm/yr for past several years is reason for improvement in SSS. Check out remodeled stores; they are attractive to new customers, and pharmecy is getting customers from Walgreen.
read the 10Q for replies to bears.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions